While pregnant women are included in those thought to be at high risk for COVID-19, not much is actually known yet about the virus' potential impacts on pregnancy.

But a University of Washington obstetrician and professor hopes to change that, shifting her lab's research into the new virus.

When we asked you to submit questions for three Seattle-area leaders about the COVID-19 pandemic, you responded in droves.

In less than 24 hours, Seattle Times readers submitted more than 400 questions for our video interview Thursday with our three panelists:

Patricia García, Peru's former Minister of Health and an Affiliate Professor of Global Health at the University of Washington, spoke to Publimetro in her home country of Peru about the country's response to the coronavirus pandemic. García received a Masters of Public Health at UW and is also a professor at the School of Public Health at Cayetano Heredia University in Lima, Peru. Her areas of expertise include epidemiology, infectious diseases, and implementation science.

The following interview has been translated from Spanish. 

In parts of Africa, where the HIV rate is 36 percent, researchers tested out a simple idea: They made access to care easier for people living with a chronic condition.

In a nearly three-year study in South Africa and Uganda, researchers used mobile vans in five communities to dispense care and treatment to 1,315 people living with HIV and not on antiretroviral treatment.

The randomized controlled trial, conducted between May 2016 and March 2019, found that viral suppression was 74 percent, compared to 63 percent for those seen in a clinic.